QUOTE AND NEWS
The Economic Times  Feb 26  Comment 
FMS students received 60 pre-placements offers this year, a 58% increase over last year. There was a 25% increase in the number of offers.
Reuters  Feb 25  Comment 
* Says to focus on small and medium sized takeovers, not the time for large takeovers
Benzinga  Feb 25  Comment 
Fresenius SE & Co. KGaA (OTC: FSNUY) reported a rise in its profit for the full year and lifted its dividend by 6%. For the fourth quarter, the company's net profit declined 9.5% to EUR257 million from EUR284 million. Annual EPS rose 4% to 1.97...
Reuters  Feb 16  Comment 
Fresenius Kabi has sold its German oncology business CFL GmbH to fellow compounding company NewCo Pharma GmbH for an undisclosed amount, the company said on Monday.
FiercePharma  Dec 1  Comment 
French company Danone hasn't had much luck so far hawking its medical nutrition business--and bidder Fresenius may be set to walk away, Reuters reports.
Wall Street Journal  Nov 28  Comment 
German health-care company Fresenius SE & Co. KGaA is set to withdraw from the bidding for the medical-nutrition business of French dairy-products group Danone SA, two people familiar with the matter said.
MarketWatch  Nov 20  Comment 
Fresenius and European buyout firm Permira have made a joint bid for Danone’s unit, as the French group pushes to advance a sale that has run into several road bumps.
Reuters  Nov 20  Comment 
The German medical group Fresenius and the Permira investment fund have made an offer for the medical nutrition arm of Danone , The Wall Street Journal reported on Wednesday,...
Wall Street Journal  Nov 19  Comment 
German health care group Fresenius SE & Co. KGaA and European buyout firm Permira have made a joint bid for Danone SA’s medical nutrition business, according to people familiar with the matter, as the French group pushes to advance a sale that...





You may also be interested in articles related to Fresenius Medical Care (FMS):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki